AGP Executive Report
Last update: 3 hours agoEarthquake Response: A magnitude-7 quake in Xizang’s Nagqu region has killed 16 people and injured 76, with hundreds of homes damaged. More than 5,000 personnel are supporting rescue, medical care and relief efforts. Cancer Care: China has completed a demonstration unit of a domestically developed heavy-ion cancer therapy accelerator in Guangdong. Testing is underway, with clinical trials expected by year-end. Obesity Treatment: J.P. Morgan estimates the China, India and Brazil market for GLP-1 drugs could reach US$22 billion by 2035, as lower prices and wider access drive uptake. Drug Approvals: China’s drug regulator has approved Harbour BioMed’s batoclimab injection for generalized myasthenia gravis, while Beijing is also fast-tracking novel medicines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.